Publication & Citation Trends
Publications
0 total
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist OA
Cited by 13
Semantic Scholar
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63) OA
Cited by 22
Semantic Scholar
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials
Cited by 18
Semantic Scholar
Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors OA
Cited by 17
Semantic Scholar
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients OA
Cited by 85
Semantic Scholar
Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Cited by 0
Semantic Scholar
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases OA
Cited by 41
Semantic Scholar
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate OA
Cited by 14
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(45)
Cancer Immunotherapy and Biomarkers
(21)
vaccines and immunoinformatics approaches
(17)
CAR-T cell therapy research
(13)
T-cell and B-cell Immunology
(10)
Affiliations
Carter Center
University of Utah
University of Virginia Health System
Huntsman Cancer Institute
University of Virginia Medical Center